Tue.Jan 24, 2023

article thumbnail

Call to arms as UK falls back in medicines manufacturing

Pharma Phorum

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition.

105
105
article thumbnail

AstraZeneca’s newest asthma launch fills a gap as generics chip away at respiratory flagships

PharmaVoice

A longtime leader in the respiratory space, AstraZeneca has hammered another stake in the ground with its newest asthma treatment, Airsupra

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Nine for 2023, part three: thriving or surviving?

Pharma Phorum

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

article thumbnail

Physician Opinions on Burnout in 2022 – Blog

InCrowd

In November of 2022, InCrowd surveyed 500 US physicians to track burnout. In 2022, reports showed that physician burnout had risen to frightening levels.

91
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.

article thumbnail

Can genetic data be a magic bullet for drug R&D?

Pharma Phorum

Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments. Ben Hargreaves finds that the vast amount of genetic data that exists today could help provide a faster, more targeted way of developing new drug candidates.

article thumbnail

Can machine learning accelerate drug formulation?

Outsourcing Pharma

Research emerging from the University of Toronto found that using machine learning models was able to guide the design of long-acting drug formulations. Clinical Development

130
130

More Trending

article thumbnail

Hospital, health system boards saw low turnover, slow diversity gains from 2018-2022, AHA finds

Fierce Healthcare

Hospital, health system boards saw low turnover, slow diversity gains from 2018-2022, AHA finds dmuoio Tue, 01/24/2023 - 10:23

Hospitals 109
article thumbnail

Largest global clinical site hires all-female key leaders in Europe

European Pharmaceutical Review

Velocity Clinical Research , the largest integrated research site organisation globally, has made three all-female key leadership hires. This move strengthens its European senior executive team as the firm continues its expansion in the region.

90
article thumbnail

With the X-waiver repealed, officials urge providers to begin prescribing buprenorphine for opioid addiction

Fierce Healthcare

With the X-waiver repealed, officials urge providers to begin prescribing buprenorphine for opioid addiction dmuoio Tue, 01/24/2023 - 14:52

105
105
article thumbnail

Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo

Fierce Pharma

Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo fkansteiner Tue, 01/24/2023 - 16:13

85
article thumbnail

Blues to press Congress to expand site-neutral payment reforms to more outpatient clinics

Fierce Healthcare

Blues to press Congress to expand site-neutral payment reforms to more outpatient clinics rking Tue, 01/24/2023 - 11:30

98
article thumbnail

Amazon unveils $5 subscription service for generics

Pharma Phorum

Efforts by Amazon to disrupt the healthcare sector just stepped up a gear, with the launch of a subscription service for Prime members that will ship generic medicines to patients’ homes in return for a $5 monthly fee.

article thumbnail

Industry Voices—Key to rural hospital survival: Sustainable solutions for patient financial engagement

Fierce Healthcare

Industry Voices—Key to rural hospital survival: Sustainable solutions for patient financial engagement hlandi Tue, 01/24/2023 - 09:47

article thumbnail

US FDA clears Transcenta’s IND for Rett syndrome treatment

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted clearance for Neurogene’s investigational new drug (IND) application for NGN-401 to treat Rett syndrome.

article thumbnail

Providers jostle to lead way if FDA makes COVID vaccination a yearly jab

Fierce Healthcare

Providers jostle to lead way if FDA makes COVID vaccination a yearly jab fdiamond Tue, 01/24/2023 - 08:46

article thumbnail

Bayer’s oncology business looks to collect $10B in sales by 2030, exec says

Fierce Pharma

Bayer’s oncology business looks to collect $10B in sales by 2030, exec says zbecker Tue, 01/24/2023 - 09:14

80
article thumbnail

Managed care plans, states can now text Medicaid beneficiaries to warn of enrollment changes

Fierce Healthcare

Managed care plans, states can now text Medicaid beneficiaries to warn of enrollment changes rking Tue, 01/24/2023 - 13:59

91
article thumbnail

Georgia Tech spinout bags cash for nucleic acid delivery R&D

Fierce Pharma

Georgia Tech spinout bags cash for nucleic acid delivery R&D ntaylor Tue, 01/24/2023 - 10:10

79
article thumbnail

Leveraging Real-World Patient Journeys at Scale for Clinical Trial Strategies

PharmExec

Readily available real-world data and advanced solutions are being used to stitch together the full patient journey, and these longitudinal insights are being used to identify and characterize trial populations and inform clinical trial design and execution strategies.

52
article thumbnail

Advancing node-to-brain delivery, team treats stoke in rodents using intranasal antibody

Fierce Pharma

Advancing node-to-brain delivery, team treats stoke in rodents using intranasal antibody ntaylor Tue, 01/24/2023 - 05:45

76
article thumbnail

Neuraxpharm completes its presence in Benelux

Pharma Mirror

article thumbnail

Colorcon Acquires Airnov Healthcare Packaging

Pharmaceutical Commerce

Transaction expected to close early this year us

article thumbnail

Modernizing Therapeutic Cell Production

Pharma Mirror

Science-based innovation for manufacturing high quality cells challenges dogma and terminology Cell and gene therapies are dominating the world of drug development.

52
article thumbnail

Physician Opinions on Burnout in 2022 – Report

InCrowd

In November of 2022, InCrowd surveyed 500 US physicians to track burnout. Download the full report to learn more about this research. The post Physician Opinions on Burnout in 2022 – Report appeared first on InCrowd. Report

52
article thumbnail

Novo Nordisk accused of violating FDA’s Fair Balance advertising policy

Pharmafile

Advocacy group, the Physicians Committee for Responsible Medicine, has accused Novo Nordisk of breaching FDA’s Fair Balance policy after Novo Nordisk’s weight loss drug Wegovy appeared on CBS’s 60 Minutes news segment about obesity. read more Sales and Marketing

FDA 52
article thumbnail

AmerisourceBergen to Update Name to Cencora

Pharmaceutical Commerce

Reflects company’s identity and pharma supply chain impact us

52
article thumbnail

Diabetes drug, originally developed for cats, approved for human use

Pharmafile

TheracosBio has announced that the first oral SGLT2 inhibitor, bexaflilozin, has been approved by the FDA for the treatment of adult patients with type 2 diabetes. The drug was originally indicated for cats with diabetes.

FDA 52
article thumbnail

Report reveals murky picture of clinical trial diversity gains

PharmaVoice

Data discrepancies between study phases and indications could provide clues about why some trials have better racial and ethnic diversity than others

52
article thumbnail

WHO issues a “call to action” after cough syrup deaths

Pharmafile

WHO has released an urgent “call to action” to all 194 WHO member states in order to try and prevent, detect and respond to incidences of illegitimate medical products.

article thumbnail

Charles Collier Joins Fuld & Company as Senior Vice President, Consulting Research & Analytics

Fuld

BOSTON – Jan 24, 2023 – Fuld & Company, a fast-growing research, analytics, and advisory business, today announced the appointment of Charles Collier to the role of Senior Vice President, Consulting Research & Analytics.

52
article thumbnail

Europe plans further antibiotic shortage countermeasures

Pharmafile

With respiratory infections increasing, an ongoing cost of living crisis and the Russia-Ukraine conflict, officials throughout Europe are beginning to look into contingency plans to deal with the concerning shortages of certain antibiotics.

FDA 52
article thumbnail

Sandoz bulks up with Mycamine ahead of spin-off

Pharma Phorum

With a separation from parent company Novartis now confirmed, Sandoz has moved to strengthen its revenue base with the acquisition of global rights to mainstay antifungal drug Mycamine from Japan’s Astellas.

article thumbnail

Amber Therapeutics announces successful first-in-human implants of Amber-UI: an intelligent, closed-loop bioelectrical therapy for urge and mixed urinary incontinence

Pharmafile

52
article thumbnail

Sanofi, CytoReason expand AI deal into IBD

Pharma Phorum

Tech company CytoReason has announced it has signed a multi-year, multimillion dollar deal with Sanofi to deliver artificial intelligence (AI) for drug discovery and development in the field of inflammatory bowel disease (IBD).

article thumbnail

finnCap Cavendish advises on the sale of Therapy Equipment Limited to ESAB Corporation

Pharmafile

Published date: 24/01/2023 Summary: London, 24th January - finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised on the sale of Therapy Equipment Limited to ESAB Corporation. Founded in 1983, Therapy Equipment Ltd.

52
article thumbnail

Eyeing tissue targeting, AstraZeneca consortium gets cash for nucleic acid delivery work

Fierce Pharma

Eyeing tissue targeting, AstraZeneca consortium gets cash for nucleic acid delivery work ntaylor Tue, 01/24/2023 - 05:42

67